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Tuberculosis is responsible for about 8 million deaths worldwide annually. The emergence of multidrug-resistant and 
extensively drug-resistant strains urgently requires the development of new drugs against tuberculosis. Drug discovery from 
plants against tuberculosis is an exciting area for exploration. In the present study, the fatty acids- linoleic and oleic acids 
isolated and identified from the seeds of the plant Mesua ferrea L. exhibited antimycobacterial activity. The analysis  
was done using Gas Chromatography-Mass Spectrometry and supplementary information was obtained using fourier 
transform-infra red and 1H and 13C nuclear magnetic resonance. The minimum inhibitory concentration of the purified 
fraction containing both the compounds was found to be 78 µg/mL. In silico molecular docking studies against the target 
proteins GlfT2, Inh A and mtKasB of Mycobacterium tuberculosis revealed high scores for both the compounds. 
Cytotoxicity studies of the compounds revealed no toxicity and high antioxidant activity was observed. 
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Introduction 
Tuberculosis, an infectious disease, caused by the 
microorganism Mycobacterium tuberculosis has 
been infecting human beings since ages1. It has been 
found to be the leading cause of death amongst  
all infectious diseases afflicting humans2. The  
World Health Organization in its recent update on 
tuberculosis reported that in 2013 alone, there were 
nearly 9 million new TB cases of which 1.1 million 
cases included Human immunodeficiency virus-
infected people. In 2013, 1.5 million died of 
tuberculosis which includes 5,10,000 women and 
3,60,000 number of Human immunodeficiency 
virus-infected individuals3. In view of the alarming 
global assessment of the disease in the context of the 
emerging threats from multidrug resistance and 
extensively drug-resistant strains of M. tuberculosis 
against the conventional first and second line drugs, 
there is an urgent need for discovering/developing 
new antimycobacterial agents. The World Health 
Organization declared tuberculosis as an emerging 
disease in the early nineties due to the emergence of 
drug-resistant strains and the increase in the incidence 
of co-infection in Human immunodeficiency virus-
infected patients4,5. The frontline antituberculosis 
drugs that are effective in treating acute tuberculosis 
are found to be inactive in eliminating  
M. tuberculosis during the persistent stages of latent 
infection6. Thus therapeutics directly targeting  
the persistent bacilli are also urgently needed.  
A new infection, reactivation of latent tuberculosis 
and the emergence of drug-resistant strains of  
M. tuberculosis led to the increased demand  
for new chemotherapy regimens7. No new drug  
has been discovered since the advent of rifampicin  
in 19638.  
Natural products or their derivatives form an 
important avenue for the search of new 
antitubercular agents7. Plants as a source of  
natural products provide an exciting field for  
the discovery of new drug leads and new  
chemical entities. Plants have been utilized as 
medicines for thousands of years in many parts of 
the world9. Plant-based drug discovery resulted 
mainly in the development of anti-infectious agents 
and continues to forward many new leads now in 
clinical trials10.  
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In the present investigation, the antimycobacterial 
activity of the natural products present in the hexane 
extract, obtained from the seeds of Mesua ferrea L.  
is being highlighted and the compounds identified.  
M. ferrea was selected for the study because of its 
wide use as a traditional medicinal plant. In Assam, 
the plant is widely used as an antiseptic, blood 
purifier and as a worm controller11. The antioxidant, 
cytotoxicity and in silico docking investigation have 
also been carried out to identify the potent targets. 
 
Materials and Methods 
 
Bacterial strain  
The strain Mycobacterium smegmatis MC2155 was 
used for the study. The strain was purchased  
from the Microbial Type Culture Collection and Gene 
Bank, The Institute of Microbial Technology, 
Chandigarh. The mycobacterial strain was grown in 
Middlebrook 7H9 broth (Himedia, India) medium 
supplemented with 0.2 % Glycerol and 10 % Oleic 
acid-Albumin-Dextrose-Catalase (OADC) media as 
prescribed in the manufacturer’s instruction. The 
strain was stored for further use by preparing glycerol 
stocks and kept at -86 °C. Before each experiment, the 
strain was checked for any contamination using the 
acid-fast staining procedure. 
 
Plant collection and identification 
The seeds of the plant M. ferrea were collected 
from the Tezpur University campus during the month 
of January-February 2012. The seeds were washed 
and dried to remove any impurities present. The plant 
is well known and was identified by Mr Jintu Sharma, 
Taxonomist and Senior Technical Assistant and a 
voucher specimen (No TUMBBT/2012/005) was 
deposited in the repository of Department of MBBT, 
Tezpur University. 
 
Extraction of crude extracts 
Solvent extraction with hexane was carried out in 
the Soxhlet apparatus for the isolation of the crude 
extract from the seeds of M. ferrea by using a slightly 
modified method previously described12. The solvent 
was evaporated using a Rotavapor (Hahn Shin 
Scientific, South Korea) and the hexane extract 
obtained was dried over anhydrous sodium sulfate to 
remove moisture. 
 
Purification of the hexane extract 
The hexane extract of the seeds of M. ferrea was 
purified using a silica gel (60-120 mesh size) column. 
A solvent mixture of petroleum ether and ethyl 
acetate in three different ratios, 10:90, 30:70 and 
50:50 was used as the eluent. The purified oil was 
dried over anhydrous sodium sulfate and kept in a 
desiccator vacuum until further use. 
 
Preparation of fatty acid methyl esters  
Fatty acid methyl esters were prepared from the 
hexane extract of the seed for identification of the 
compounds. To obtain the methyl esters 1 mL of the 
hexane extract was taken in a test tube and mixed 
with 2 mL of chloroform, 4 mL of methanol and  
500 µL of concentrated sulfuric acid and heated at 
100 °C for about 2 hours. The extract-solvent-acid 
mixture was cooled to room temperature and 3-4 mL 
of hexane was added to it and mixed. The hexane 
fraction was collected and analyzed.  
 
GC-MS analyses of the fatty acid methyl esters 
The gas chromatography-mass spectrometry 
analyses of the fatty acid methyl esters were  
carried out in a Varian-3800 GC/FID coupled to a 
SATURN-2200 Mass spectrophotometer using a 
CP-Sil 5 CB low bleed/MS (30 m x 0.25 mm x 0.25 µm) 
column as described previously13 with certain 
modifications. The temperature of the oven was set 
using the following conditions: initial temperature set 
at 80 °C was held for 1 minute, then increased at a 
rate of 8 °C/ min and held for 15 minutes. Exactly 1 
µL of sample was injected for the analysis. Data 
acquisition was done for the mass range between  
50-550 mu and the scan speed was 1 scan/sec. 
Compound identification was done using both the 
NIST library and the SATURN library available with 
the instrument and also the retention time of the peaks.  
 
Fourier transform infrared analysis of the essential oil 
Fourier transform infrared analysis of the essential 
oil was carried out to investigate the functional groups 
present. The analysis was carried out in a Perkin 
Elmer Spectrum 100 Series IR spectrophotometer 
using potassium bromide discs. The spectra were 
taken in the absorbance mode and each sample was 
scanned 8 times with a scan speed of 4 cm/ sec 
starting from 400–4000/ cm. 
 
Nuclear magnetic resonance of essential oil 
1H NMR and 13C NMR were carried out using a 
400 MHz JEOL FT-NMR. Tetramethylsilane was the 
internal standard. NMR grade CDCl3 was used as  
the solvent, while a pulse width of 9.5 µsec and 
acquisition time of 2.83 sec was taken. A total of  
8 scans were performed.  
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Antimycobacterial activity of M. ferrea seed oil 
The antimycobacterial activity of the seed hexane 
extract of M. ferrea was determined by using 96 well 
plates following the method previously described14. A 
stock solution of the hexane extract was prepared at a 
concentration of 20 mg/mL. Various concentrations of 
the extract were prepared in aliquots in DMSO by 
serial dilution from the stock solution keeping the 
final concentration of dimethyl sulfoxide at 1 %. 
Exactly 100 µL of each was added to each well.  
To this, 100 µL of the bacterial inoculum relating  
to 0.5 Mc Farlands Standard was added. Isoniazid 
(0.02 mg/mL) was taken as the positive control  
while dimethyl sulfoxide (1 %) was the negative 
control. Plates were then incubated at 37 °C for  
24 hours. After the incubation period, 40 µL of MTT  
(3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide) was added and again incubated for about  
30 minutes. A colour change to blue indicated the 
growth of bacteria while no change in colour 
indicated the antibacterial effect of the hexane extract. 
 
Cytotoxicity of the essential oil fraction 
The cytotoxicity of the purified essential oil 
fraction was assayed against RAW 264.7 macrophage 
cell lines. The cells were cultured in Dulbecco’s 
Modified Eagle’s Medium complete media 
supplemented with 10 % Fetal Bovine Serum  
and 100 µL of penstrep (Penicillin:Streptomycin) 
antibiotic reagent (Sigma). Cells were seeded into  
96 well plates (NUNC, USA) and allowed to grow 
until confluency was attained. To the seeded cells, 
essential oil was added in the concentration range of 
1, 5, 10, 20, and 40 µL. The plates were incubated at 
37 °C for 12 hours. 30 µL of 3-(4,5-Dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium Bromide was added to 
the plates. After incubation, any change in colour was 
indicative of toxicity of the hexane extract. 
 
Antioxidant activity of the essential oil 
Antioxidant activity of the essential oil was 
determined by the DPPH ((3-(4,5-Dimethylthiazol-2-
yl)-2,5-Diphenyltetrazolium Bromide) assay as 
previously reported15. DPPH free radicals were 
prepared in methanol at a concentration of 0.004 %. 
Different concentrations (0.062-1 mg/mL) of the 
essential oil fraction exhibiting antimycobacterial 
activity from M. ferrea seed was taken. The absorbance 
was read at 517 nm in a spectrophotometer (Thermo 
Fischer) after incubation for 30 minutes in dark at 
room temperature. Inhibition of DPPH free radical  
in percentage (I %) was calculated using the 
following formula.  
I % = (A blank- A sample/A blank) x 100 
where ‘A blank’ is the absorbance of the control 
reaction containing all the reagents except the extract. 
‘A sample’ is the absorbance of the extract, i.e., the 
test compound. The concentration of the extract that 
provided 50 % inhibition was calculated from the 
graph plotting inhibition percentage against the 
extract concentration. All the tests were carried out in 
triplicates. Ascorbic acid was taken as the standard.  
 
In silico investigation 
 
Molecular docking  
Molecular Docking studies were carried out using 
Molegro Virtual Docker (MVD) 5.016. The scoring 
functions of the ligands and the H-bonds formed with 
the amino acids were used in the prediction of the 
binding affinities, different binding modes and 
orientation of the compounds in the active site(s) of 
the target proteins. The water molecules were not 
taken into account in the study. The cavity detection 
algorithm in MVD was used for optimizing the 
potential binding site(s), i.e., it enables to define an 
approximate location of the most likely interaction 
sites. A set of 100 runs was given for each docking 
study using 2000 interactions. Both the Rerank scores 
and the MolDock scores were calculated. The  
best-fit score was obtained on the basis of the 
Moldock score17. 
 
Selection of the target proteins 
The target proteins chosen for the study were 
downloaded from the Protein Data Base18. Three 
target proteins, Inh A (2B35), mtKas B (2GP6) and 
Glft2 (4FIX) were considered for the study based on 
their activity of synthesizing mycolic acids in both M. 
tuberculosis and M. smegmatis. Inh A is the enoyl 
ACP reductase protein of the mycobacterial type II 
fatty acid biosynthesis pathway. Inh A is the target of 
the first line anti-tuberculosis drug isoniazid. Inh A 
inhibition impairs the cell wall integrity which leads 
to the death of the cell and finally death of the 
organism19. The M. tuberculosis Kas B is a β ketoacyl 
acyl carrier protein synthase (ACP) II which is an 
elongation condensing enzyme present in the fatty 
acid synthase II (FAS-II) pathway. The Kas B along 
with Kas A is responsible for the fatty acid elongation 
in the FAS II pathway. Therefore the Kas B protein is 
considered as a potential target for anti-tuberculosis 
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drug candidate20. GlfT2 (Rv 3808c) is a polymerizing 
galactofuranosyltransferase which is involved in the 
synthesis of a variety of the galactan portion of the 
mycolyl arabinogalactan (MAG) complex in M. 
tuberculosis. This galactan is the attachment site of 
three different arabinan domains each of which 
contains ά- (1 5), ά- (1 3) and β - (1 2) linked 
arabinofuranose residue21.  
 
Results  
 
Purification of the essential oil from M. ferrea seed 
 
Column chromatography 
The column chromatographic purification led to the 
identification of the active fraction-F2 which was 
further investigated to identify the compounds present 
within the fraction. The seed extract of M. ferrea in 
hexane was purified using different solvent ratios of 
petroleum ether and ethyl acetate. The maximum 
amount of the extract was eluted in the petroleum 
ether: ethyl acetate 10:90 solvent medium. The 
elution was divided into three fractions (F1-F3). Each 
of the fractions was again tested for their 
antimycobacterial activity using the MIC activity test. 
It was found that the fraction F2 possessed 
antimycobacterial activity while fraction F1 showed 
limited activity and F3 no activity. Therefore the 
fraction F2 was further analyzed using GC-MS to 
identify the compounds present. 
 
Gas chromatography-mass spectrometry (GC-MS) 
GC-MS studies led to the identification of the 
active compounds. The F2 fraction obtained from 
column chromatography was converted into fatty acid 
methyl esters (FAMEs). Exactly 1 µL of the FAMEs 
was injected into the GC-MS and analyzed to 
investigate the presence of the fatty acid components. 
The fatty acid components: palmitic acid, linoleic 
acid, oleic acid, stearic acid and arachidic acid were 
found to be present in the F2 fraction, along with 
some other unidentified compounds (Fig. 1). From the 
results, it was inferred that the compounds linoleic 
acid and oleic acid (Fig. 2) were responsible for the 
antimycobacterial activity of the fraction. Both the 
essential fatty acids have been mentioned in the 
literature for their antimycobacterial activity2.  
The fraction F2 was further analyzed using FT-IR  
and NMR. 
 
FT-IR of the F2 fraction 
The FT-IR of the essential oil extracted from the 
seeds of M. ferrea was carried out to characterize the 
 
 
Fig. 1 — GC-MS of hexane extract from the seed of Mesua ferrea L. 
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essential oils. The absorbance could be observed at 
726, 1379, 1582, 1623, 1747, 1750, 3007, 3467/cm. 
The FT-IR studies indicated the presence of various 
functional groups associated with the unsaturated 
fatty acids. The transmittance at 1379, 1582, 1747, 
1750/cm was due to the presence of symmetric and 
asymmetric C=O stretching vibration attributed to the 
carboxylic acids and at 726 and 1623/cm is due to the 
presence of alkene group. The presence of the 
hydroxyl groups could be observed at 3007 and 
3467/cm. 
 
NMR of the F2 fraction 
The 1H NMR and the 13C NMR predicted the 
presence of different carbon and proton shifts 
indicative of the presence of both the linoleic and 
oleic acid. 
 
1H NMR and 13C NMR 
The presence of the signals from 5.31-5.9 ppm is 
due to the presence of oleifinic protons of isolated 
double bonds and conjugated double bonds29. The 
presence of the α-CH2 protons and presence of 
methylene groups adjacent to the carbonyl group  
can be seen with the signals at 2.2-2.5 ppm while 
CH2-CH=CH is observed with the presence of the 
signal at 2.0 ppm. The signals from 1.2-1.6 ppm and 
0.83-0.98 ppm reflect the presence of (CH2)n and CH3 
protons which are due to the presence of terminal 
methyl resonance (Fig. 3)2,22. 13C NMR analysis 
revealed the presence of all the major groups present 
in the fatty acids. All the characteristic peaks as 
previously described have been found to be present in 
the analysis. In the analysis of fatty acids (lipids) the 
characteristic signals of 13C NMR are grouped in four 
different regions. From 172-178 ppm the carbonyl 
and carboxyl carbons are present while from  
124-134 ppm the unsaturated carbons are found, the 
glycerol backbone carbons can be observed in 
between 60–72 ppm and finally from 10-35 ppm the 
aliphatic carbons are found. In the present study, all 
the characteristic signals have been found to be 
present. From 14.19-32.00 ppm the presence of the 
aliphatic carbons, the 62.17-68.91 presence of glycerol 
backbone carbon, 129.76-130.09 demonstrated the 
presence of unsaturated carbons and the carbonyl and 
carboxyl carbons in between 172.98-173.43. The δC at 
24.8, 25.7 and 27.3 is due to the presence of the 
saturated monoene and diene chain, a total number of 
diene chains and twice the total number of monoene 
and diene chains. The δC at 129.76 and 129.78 is due 
to the presence of the C10 and C9 of the oleic chain 
while the smaller signals at δC 130.09, 129.9, 128.1 
and 127.9 were due to the C13, C9, C10 and C12 of 
linoleic chain present in the essential oil component 
(Fig. 4)2,29. Thus the presence of both oleic acid and 
linoleic acid are found to coincide with the details 
documented in the literature which correlated with our 
analysis and demonstrated their presence in the 
hexane extract. 
 
MIC of the purified compounds 
The MIC of the essential oil fraction revealed  
the minimum concentration at which the growth of 
the bacteria was inhibited. It was found that the 
linoleic and oleic acid containing essential oil fraction 
of M. ferrea inhibited the bacteria at 78 µg/mL. The 
minimum inhibitory concentration (MIC) of the 
positive fraction containing both the compounds were 
found to match with the literature. The inhibitory 
mechanism of the fraction showing the antimycobacterial 
property is due to its detergent like properties2. 
 
Cytotoxicity assay of the purified compounds  
The purified essential oil was investigated for their 
cytotoxicity using RAW 264.7 macrophage cell lines. 
 
 
Fig. 2 — Structures of linoleic acid and oleic acid present in the essential oil fraction. 
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The essential oil was applied directly at different 
concentrations of 1,5,10, 20 and 40 µL into the  
96 well plates in which the cells were seeded. The 
plates were incubated in a CO2 incubator at 37 °C  
for 12 hours and then estimated for cytotoxicity  
using MTT. None of the concentrations of the 
essential oil was found to be toxic to the cells  
thus indicating that the compounds were not cytotoxic 
to the cell line Raw 264.7. 
 
Antioxidant assay of the purified compounds 
The antioxidant activity of the essential oil fraction 
containing linoleic acid and oleic acid were assayed 
using the DPPH free radical scavenging method. For 
the essential oil fraction, the concentrations ranged 
from 0.062-1 mg/mL. It was observed that at the 
highest concentration the oil fraction showed more 
than 93 % inhibition of DPPH free radical. Ascorbic 
acid taken as the positive control showed 97 % 
inhibition, slightly more than the tested samples. Thus 
the antioxidant studies of the compounds also 
indicated high radical scavenging activities of the 
compounds thus suggesting that the compounds are 
able to inhibit the formation of free radicals. The 
higher antioxidant property of the essential oil 
indicated pharmacological significance. 
 
In silico investigation of the identified compounds  
Linoleic acid and oleic acid identified as the 
antimycobacterial compounds from the F2 fraction of 
M. ferrea L. were docked with the target proteins with 
2000 iterations. The efficiency of docking is predicted 
 
 
Fig. 3 — 1H NMR spectra of the antimycobacterial purified fraction. 
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by the scoring functions from which the biological 
activity of the molecules can be evaluated23. 
Both linoleic and oleic acids exhibited different 
docking affinities (Fig. 5 and 6) with the galacto-
furanosyltransferase protein from M. tuberculosis. 
Linoleic acid exhibited a MolDock score of -102.787 
and a Rerank score of -85.5168 while oleic acid 
demonstrated a score of -101,424 and a Rerank score 
of -82.1008. The amino acid residues present in the 
cavity of the target protein which interacted with 
linoleic acids are Glu 300, Tyr 344 and Asp 372 with 
bond distances of 2.24 Å, 1.56 Å and 2.81 Å and 
those interacting with oleic acids are Lys 369, Trp 
348 and Tyr 236 with bond distances of 1.77 Å,  
2.59 Å and 2.74 Å. In case of Inh A, oleic acid 
demonstrated the best Moldock score of -112.575 and 
a Rerank score of -89.2977 while linoleic acid 
exhibited -103.844 and -83.5622 as Moldock and 
Rerank scores respectively. The residual amino acids 
interacting with the ligand linoleic acid were Arg 173, 
Ser 152, Tyr 259 and His 265 with bond distances of 
2.52 Å, 2.61 Å 2.91 Å and 2.69 Å while the 
interacting amino acids with oleic acid were Asp 150, 
Ser152, Tyr 259, Ile 257, His 265, Asp 256 with bond 
distances of 3.62 Å, 1.87 Å, 3.07 Å, 1.98 Å, 2.84 Å 
and 2.12 Å. In the case of Inh A. commonality was 
observed with respect to the amino acid residues in 
both linoleic acid and oleic acid- Ser152, Tyr 259,  
 
 
Fig. 4 — 13C NMR spectra of the antimycobacterial purified fraction. 
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His 265 interacting with the ligands. In the case of 
mtKas B, Pro 138, Val 278, Met 277, Arg 200 and 
Glu 198 were found to the interacting amino acid 
residues having bond distances of 3.22 Å, 2.31 Å, 
2.27 Å, 2.55 Å and 2.73 Å with linoleic acid which 
docked with the target protein with a Moldock score 
of -114.496 and a Rerank score of -59.0288 while 
Oleic acid docked with a Moldock score of -91.369 
and a Rerank score of -24.2144 and Gly 406, His 408, 
Asn 147, Phe 405, Gln 142, Glu 198 and Gly 240 as 
the residual amino acids interacting with the molecule 
having bond distances of 2.21 Å, 3.24 Å, 3.07 Å, 1.89 
Å, 2.98 Å, 2.97 Å and 3.43 Å. 
The Moldock calculation is based on a score  
which is derived from PLP scoring function24,27. 
Interestingly the MolDock scoring function further 
improved the scoring functions with new charge 
schemes and hydrogen bonding terms. Escore, the 
docking scoring function is defined as  
Escore =Einter+Eintra 
where, Einter is the ligand-protein interaction energy 
and Eintra is the internal energy of the ligand. 
The Rerank score obtained is actually a linear 
combination of Einter (Van der Waals, electrostatic, 
hydrogen bonding, steric) between the protein and the 
ligand and Eintra (hydrogen bonding, torsion, Van der 
Waals, sp2-sp2, electrostatic) of the ligand weighted 
by predefined coefficients 26. 
Therefore, the potential of the compounds as 
antimycobacterial was further justified on the basis of 
their in silico docking studies. The three target 
proteins chosen, play very important roles with 
reference to mycolic acid synthesis which is essential 
for the maintenance of the impermeability of the cell 
wall by most drugs. However, it was observed that 
both the compounds docked with all the three target 
proteins- Glf T2, Inh A and mtKas B. Linoleic acid 
docked better in case of Glf T2 and mtKas B while in 
the case of Inh A, oleic acid was found to be efficient 
than linoleic acid.  
 
 
 
Fig. 5 — Docking study of linoleic acid with 2B35 (a,d), 2GP6 (b,e) and 4FIX (c,f) where a,b,c represents protein target in 2° structure 
view and d,e,f represents ligand docking within the protein cavity. 
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Discussion 
Medicinal plants have been widely investigated 
over the years for their potentiality in the treatment of 
several diseases including tuberculosis. Natural 
products obtained from plants have been the  
main source of alternative drugs for the treatment  
of several human ailments. Plants produce a variety  
of secondary product molecules like phenolics, 
flavonoids, terpenoids etc which have different 
pharmacological properties. 
Linoleic acid and oleic acid identified from the 
hexane extract of the M. ferrea plant has been 
reported earlier to possess antimycobacterial 
properties28. The minimum inhibitory concentration of 
the fraction containing the active compounds 
correlated with earlier findings28.  
The presence of the compounds in the hexane 
extract has been demonstrated which is responsible 
for the antimycobacterial activity of the hexane 
extract. Gas chromatographic-mass spectrometric 
analysis revealed the presence of linoleic and oleic 
acid in the hexane extract. Fourier transform infrared 
analysis revealed the different functional groups, 
representative of both linoleic acid and oleic acid, 
present in the active fraction which yielded the 
compounds. Nuclear magnetic resonance (NMR) 
studies revealed the presence of different fatty acids 
in the hexane extract including oleic acid and linoleic 
acid. NMR is a widely used instrument in the analysis 
of fatty acids. Both 1H NMR and 13C NMR are used 
in the identification of molecules without going for 
individual isolation. Different signals were visualized 
from both the 1H NMR and 13C NMR study which 
revealed the presence of both linoleic and oleic acid in 
the hexane extract. In silico docking studies revealed 
the potential docking of the active compounds in the 
target proteins which demonstrated their 
antimycobacterial properties. Efficient docking of 
linoleic and oleic acid with the target proteins 
involved in mycolic acid synthesis reveals the 
potential activity of both the molecules.  
The active fractions were found to be non-cytotoxic 
suggesting their potential advantage over other synthetic 
drugs and also demonstrated high antioxidant activity. 
 
 
Fig. 6 — Docking study of oleic acid with 2B35 (a,d), 2GP6 (b,e) and 4FIX (c,f) where a,b,c represents protein target in 2° structure view 
and d, e, f represents ligand docking within the protein cavity. 
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Thus the present study demonstrated the presence of the 
compounds linoleic acid and oleic acid in the hexane 
extract of the M. ferrea seeds which were responsible for 
the anti-mycobacterial against M. smegmatis. 
 
Conclusion 
Plants are a rich storehouse of diverse chemical 
compounds. Drug-like molecules obtained from 
plants offers an alternate choice over conventional 
synthetic drugs. In the present study, the search for 
antimycobacterial plant metabolites led to the 
identification of linoleic and oleic acid from  
M. ferrea L. Characterization of the compounds  
was carried out using GC-MS, FT-IR and 1H and  
13C NMR studies. No toxicity was observed against 
the Raw 264.7 cell line. Docking studies using the  
M. tuberculosis target proteins GlfT2 and Inh A 
indicated the docking efficacy of linoleic acid over 
oleic acid with better docking scores of -54.0174 and 
-79.1535 as against -33.5739 and -74.884 exhibited 
by oleic acid. The MIC study of the purified fraction 
containing both the compounds were found to be 
higher with a concentration of 78 µg/mL which 
suggested that the compounds can be further studied 
for forwarding them as potential anti-mycobacterial 
agents. The antioxidant study also revealed the high 
antioxidant potential of the compounds which might 
be of pharmacological advantage.  
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